The optimal timing and modality of therapeutic intervention during early phases of HIV infection is still debated; in our prospective observational study we evaluated immunological and virological outcome in HIV+ patients treated during acute or recent HIV infection.
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI / G.M. Bottani, M.L. Oreni, G. Orofino, P. Tau, S. Di Nardo Stuppino, E. Colella, S. Carosella, M. Guastavigna, V. Ghisetti, V. Micheli, M. Galli, S. Rusconi. - In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. - ISSN 1758-2652. - 17:4, suppl. 3(2014 Nov 02), pp. 19778.175-19778.175. ((Intervento presentato al convegno International congress of drug therapy in HIV infection tenutosi a Glasgow (UK) nel 2014.
Titolo: | Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI |
Autori: | GALLI, MASSIMO (Penultimo) RUSCONI, STEFANO (Ultimo) |
Settore Scientifico Disciplinare: | Settore MED/17 - Malattie Infettive |
Data di pubblicazione: | 2-nov-2014 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.7448/IAS.17.4.19778 |
Appare nelle tipologie: | 01 - Articolo su periodico |